questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Précurseurs de protéines
Proenzymes
Proenzymes : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Carence enzymatique
Tests de laboratoire
Analyse biochimique
Imagerie médicale
Symptômes digestifs
Troubles métaboliques
Tests génétiques
Mutations
Symptômes
5
Déficience enzymatique
Symptômes digestifs
Troubles métaboliques
Problèmes digestifs
Système immunitaire
Réponse immunitaire
Symptômes neurologiques
Métabolisme cérébral
Types de proenzymes
Symptômes
Prévention
5
Habitudes de vie
Exercice
Contrôles médicaux
Détection précoce
Éducation nutritionnelle
Troubles enzymatiques
Traitements
5
Suppléments enzymatiques
Modifications diététiques
Thérapie génique
Défauts génétiques
Médicaments
Activation enzymatique
Nutrition
Production enzymatique
Complications
5
Complications digestives
Complications métaboliques
Maladies chroniques
Troubles métaboliques
Cancer
Anomalies enzymatiques
Complications réversibles
Traitement
Santé globale
Systèmes corporels
Facteurs de risque
5
Facteurs de risque
Antécédents familiaux
Âge
Troubles enzymatiques
Mode de vie
Alimentation déséquilibrée
Maladies héréditaires
Production enzymatique
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Proenzymes : Questions médicales les plus fréquentes",
"headline": "Proenzymes : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Proenzymes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-14",
"dateModified": "2026-04-03",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Proenzymes"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Précurseurs de protéines",
"url": "https://questionsmedicales.fr/mesh/D011498",
"about": {
"@type": "MedicalCondition",
"name": "Précurseurs de protéines",
"code": {
"@type": "MedicalCode",
"code": "D011498",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.811"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Chymotrypsinogène",
"alternateName": "Chymotrypsinogen",
"url": "https://questionsmedicales.fr/mesh/D002919",
"about": {
"@type": "MedicalCondition",
"name": "Chymotrypsinogène",
"code": {
"@type": "MedicalCode",
"code": "D002919",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.811.243.184"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Facteur B du complément",
"alternateName": "Complement Factor B",
"url": "https://questionsmedicales.fr/mesh/D011415",
"about": {
"@type": "MedicalCondition",
"name": "Facteur B du complément",
"code": {
"@type": "MedicalCode",
"code": "D011415",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.811.243.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Pepsinogènes",
"alternateName": "Pepsinogens",
"url": "https://questionsmedicales.fr/mesh/D010435",
"about": {
"@type": "MedicalCondition",
"name": "Pepsinogènes",
"code": {
"@type": "MedicalCode",
"code": "D010435",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.811.243.509"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Pepsinogène A",
"alternateName": "Pepsinogen A",
"url": "https://questionsmedicales.fr/mesh/D020116",
"about": {
"@type": "MedicalCondition",
"name": "Pepsinogène A",
"code": {
"@type": "MedicalCode",
"code": "D020116",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.811.243.509.700"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Pepsinogène C",
"alternateName": "Pepsinogen C",
"url": "https://questionsmedicales.fr/mesh/D020115",
"about": {
"@type": "MedicalCondition",
"name": "Pepsinogène C",
"code": {
"@type": "MedicalCode",
"code": "D020115",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.811.243.509.725"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Plasminogène",
"alternateName": "Plasminogen",
"url": "https://questionsmedicales.fr/mesh/D010958",
"about": {
"@type": "MedicalCondition",
"name": "Plasminogène",
"code": {
"@type": "MedicalCode",
"code": "D010958",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.811.243.610"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Trypsinogène",
"alternateName": "Trypsinogen",
"url": "https://questionsmedicales.fr/mesh/D014362",
"about": {
"@type": "MedicalCondition",
"name": "Trypsinogène",
"code": {
"@type": "MedicalCode",
"code": "D014362",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.811.243.885"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Proenzymes",
"alternateName": "Enzyme Precursors",
"code": {
"@type": "MedicalCode",
"code": "D004792",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Piyarat Govitrapong",
"url": "https://questionsmedicales.fr/author/Piyarat%20Govitrapong",
"affiliation": {
"@type": "Organization",
"name": "Research Center for Neuroscience, Institute of Molecular Biosciences, Mahidol University, Nakon Pathom, Thailand."
}
},
{
"@type": "Person",
"name": "Michael S Finch",
"url": "https://questionsmedicales.fr/author/Michael%20S%20Finch",
"affiliation": {
"@type": "Organization",
"name": "Department of Health Sciences, Brock University, St. Catharines, Ontario, Canada."
}
},
{
"@type": "Person",
"name": "Daniel M Marko",
"url": "https://questionsmedicales.fr/author/Daniel%20M%20Marko",
"affiliation": {
"@type": "Organization",
"name": "Department of Health Sciences, Brock University, St. Catharines, Ontario, Canada."
}
},
{
"@type": "Person",
"name": "Rebecca E K MacPherson",
"url": "https://questionsmedicales.fr/author/Rebecca%20E%20K%20MacPherson",
"affiliation": {
"@type": "Organization",
"name": "Department of Health Sciences, Brock University, St. Catharines, Ontario, Canada."
}
},
{
"@type": "Person",
"name": "Juan Francisco Martín",
"url": "https://questionsmedicales.fr/author/Juan%20Francisco%20Mart%C3%ADn",
"affiliation": {
"@type": "Organization",
"name": "Departamento de Biología Molecular, Área de Microbiología, Universidad de León, 24071 León, Spain."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Endothelial-derived complement factor D contributes to endothelial dysfunction in malignant nephrosclerosis via local complement activation.",
"datePublished": "2023-05-15",
"url": "https://questionsmedicales.fr/article/37188751",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41440-023-01300-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "Quantification of the zymogenicity and the substrate-induced activity enhancement of complement factor D.",
"datePublished": "2023-05-22",
"url": "https://questionsmedicales.fr/article/37283768",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2023.1197023"
}
},
{
"@type": "ScholarlyArticle",
"name": "Urinary complement factor D is increased in primary malignant hypertension: a single-center, cross-sectional study.",
"datePublished": "2024-07-15",
"url": "https://questionsmedicales.fr/article/39009768",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-66875-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Complement factor D regulates collagen type I expression and fibroblast migration to enhance human tendon repair and healing outcomes.",
"datePublished": "2023-09-06",
"url": "https://questionsmedicales.fr/article/37744351",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2023.1225957"
}
},
{
"@type": "ScholarlyArticle",
"name": "Plasma factor D is cross-sectionally associated with low-grade inflammation, endothelial dysfunction and cardiovascular disease: The Maastricht study.",
"datePublished": "2023-06-24",
"url": "https://questionsmedicales.fr/article/37406499",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.atherosclerosis.2023.06.079"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Précurseurs de protéines",
"item": "https://questionsmedicales.fr/mesh/D011498"
},
{
"@type": "ListItem",
"position": 5,
"name": "Proenzymes",
"item": "https://questionsmedicales.fr/mesh/D004792"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Proenzymes - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Proenzymes",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Proenzymes",
"description": "Comment diagnostique-t-on une carence en proenzymes ?\nQuels examens sont nécessaires pour évaluer les proenzymes ?\nLes proenzymes peuvent-elles être détectées par biopsie ?\nQuels symptômes indiquent un problème avec les proenzymes ?\nLes tests génétiques sont-ils utiles pour les proenzymes ?",
"url": "https://questionsmedicales.fr/mesh/D004792?mesh_terms=Complement+Factor+D#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Proenzymes",
"description": "Quels sont les symptômes d'une déficience en proenzymes ?\nComment se manifestent les troubles liés aux proenzymes ?\nLes proenzymes affectent-elles le système immunitaire ?\nY a-t-il des symptômes neurologiques associés aux proenzymes ?\nLes symptômes varient-ils selon le type de proenzyme ?",
"url": "https://questionsmedicales.fr/mesh/D004792?mesh_terms=Complement+Factor+D#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Proenzymes",
"description": "Comment prévenir les carences en proenzymes ?\nLes vaccinations aident-elles à prévenir des troubles liés aux proenzymes ?\nY a-t-il des habitudes de vie à adopter pour les proenzymes ?\nLes contrôles médicaux réguliers sont-ils importants ?\nL'éducation nutritionnelle peut-elle prévenir des troubles enzymatiques ?",
"url": "https://questionsmedicales.fr/mesh/D004792?mesh_terms=Complement+Factor+D#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Proenzymes",
"description": "Quels traitements existent pour les carences en proenzymes ?\nLa thérapie génique peut-elle aider les proenzymes ?\nLes médicaments peuvent-ils activer les proenzymes ?\nComment la nutrition influence-t-elle les proenzymes ?\nLes traitements sont-ils différents selon l'âge ?",
"url": "https://questionsmedicales.fr/mesh/D004792?mesh_terms=Complement+Factor+D#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Proenzymes",
"description": "Quelles complications peuvent survenir avec des proenzymes déficientes ?\nLes proenzymes déficientes peuvent-elles causer des maladies chroniques ?\nY a-t-il des risques de cancer liés aux proenzymes ?\nLes complications sont-elles réversibles ?\nComment les proenzymes affectent-elles la santé globale ?",
"url": "https://questionsmedicales.fr/mesh/D004792?mesh_terms=Complement+Factor+D#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Proenzymes",
"description": "Quels sont les facteurs de risque pour les troubles des proenzymes ?\nL'âge influence-t-il le risque de troubles enzymatiques ?\nLe mode de vie peut-il affecter les proenzymes ?\nLes maladies héréditaires sont-elles un facteur de risque ?\nLe stress peut-il influencer les proenzymes ?",
"url": "https://questionsmedicales.fr/mesh/D004792?mesh_terms=Complement+Factor+D#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on une carence en proenzymes ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et des analyses enzymatiques sont utilisés pour détecter les carences."
}
},
{
"@type": "Question",
"name": "Quels examens sont nécessaires pour évaluer les proenzymes ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses biochimiques et des imageries peuvent être nécessaires pour évaluer leur activité."
}
},
{
"@type": "Question",
"name": "Les proenzymes peuvent-elles être détectées par biopsie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une biopsie peut aider à évaluer la présence de proenzymes dans certains tissus."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème avec les proenzymes ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes digestifs, des douleurs abdominales ou des troubles métaboliques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils utiles pour les proenzymes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent identifier des mutations affectant la production de proenzymes."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une déficience en proenzymes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des douleurs abdominales, des nausées et des troubles digestifs."
}
},
{
"@type": "Question",
"name": "Comment se manifestent les troubles liés aux proenzymes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent se manifester par des troubles métaboliques et des problèmes de digestion."
}
},
{
"@type": "Question",
"name": "Les proenzymes affectent-elles le système immunitaire ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines proenzymes peuvent influencer la réponse immunitaire, entraînant des symptômes variés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés aux proenzymes ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes neurologiques peuvent survenir si des proenzymes affectent le métabolisme cérébral."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de proenzyme ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de la proenzyme spécifique impliquée."
}
},
{
"@type": "Question",
"name": "Comment prévenir les carences en proenzymes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en nutriments et des bilans de santé réguliers aident à prévenir les carences."
}
},
{
"@type": "Question",
"name": "Les vaccinations aident-elles à prévenir des troubles liés aux proenzymes ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations peuvent prévenir des infections qui affectent la fonction enzymatique."
}
},
{
"@type": "Question",
"name": "Y a-t-il des habitudes de vie à adopter pour les proenzymes ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, adopter un mode de vie sain, incluant exercice et alimentation équilibrée, est bénéfique."
}
},
{
"@type": "Question",
"name": "Les contrôles médicaux réguliers sont-ils importants ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des contrôles réguliers permettent de détecter précocement des problèmes enzymatiques."
}
},
{
"@type": "Question",
"name": "L'éducation nutritionnelle peut-elle prévenir des troubles enzymatiques ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'éducation nutritionnelle aide à comprendre l'importance des nutriments pour les proenzymes."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les carences en proenzymes ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des suppléments enzymatiques et des modifications diététiques."
}
},
{
"@type": "Question",
"name": "La thérapie génique peut-elle aider les proenzymes ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la thérapie génique peut corriger des défauts génétiques affectant les proenzymes."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils activer les proenzymes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains médicaments peuvent favoriser l'activation des proenzymes inactives."
}
},
{
"@type": "Question",
"name": "Comment la nutrition influence-t-elle les proenzymes ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut soutenir la production et l'activation des proenzymes."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils différents selon l'âge ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements peuvent varier selon l'âge et les besoins spécifiques du patient."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des proenzymes déficientes ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications digestives, métaboliques et immunitaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les proenzymes déficientes peuvent-elles causer des maladies chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des déficiences prolongées peuvent contribuer à des maladies chroniques et des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de cancer liés aux proenzymes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent un lien entre des anomalies enzymatiques et un risque accru de cancer."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié et une gestion adéquate."
}
},
{
"@type": "Question",
"name": "Comment les proenzymes affectent-elles la santé globale ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des proenzymes dysfonctionnelles peuvent perturber divers systèmes corporels, affectant la santé globale."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les troubles des proenzymes ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des maladies métaboliques et une mauvaise nutrition."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de troubles enzymatiques ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le risque de troubles enzymatiques augmente souvent avec l'âge en raison de la dégradation enzymatique."
}
},
{
"@type": "Question",
"name": "Le mode de vie peut-il affecter les proenzymes ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une alimentation déséquilibrée augmentent le risque de troubles."
}
},
{
"@type": "Question",
"name": "Les maladies héréditaires sont-elles un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies héréditaires peuvent affecter la production ou l'activation des proenzymes."
}
},
{
"@type": "Question",
"name": "Le stress peut-il influencer les proenzymes ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut perturber le métabolisme et affecter la fonction enzymatique."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 03/04/2026
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Affiliations :
Research Center for Neuroscience, Institute of Molecular Biosciences, Mahidol University, Nakon Pathom, Thailand.
Chulabhorn Graduate Institute, Chulabhorn Royal Academy, Bangkok, Thailand.
Publications dans "Proenzymes" :
2 publications dans cette catégorie
Affiliations :
Department of Health Sciences, Brock University, St. Catharines, Ontario, Canada.
Publications dans "Proenzymes" :
2 publications dans cette catégorie
Affiliations :
Department of Health Sciences, Brock University, St. Catharines, Ontario, Canada.
Publications dans "Proenzymes" :
2 publications dans cette catégorie
Affiliations :
Department of Health Sciences, Brock University, St. Catharines, Ontario, Canada.
Centre for Neuroscience, Brock University, St. Catharines, Ontario, Canada.
Publications dans "Proenzymes" :
2 publications dans cette catégorie
Affiliations :
Departamento de Biología Molecular, Área de Microbiología, Universidad de León, 24071 León, Spain.
Publications dans "Proenzymes" :
2 publications dans cette catégorie
Affiliations :
Departamento de Biología Molecular, Área de Microbiología, Universidad de León, 24071 León, Spain.
Publications dans "Proenzymes" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Biochemical Genetics and Metabolism, The Mitochondrial and Metabolic Disease Center, School of Medicine, University of California, San Diego, San Diego, California, USA.
Department of Pediatrics, School of Medicine, University of California, San Diego, California, USA.
Publications dans "Proenzymes" :
2 publications dans cette catégorie
Affiliations :
Department of Korean Medicine, Graduate School, Kyung Hee University, 26, Kyunghee dae-ro, Dongdaemun-gu, Seoul, 02447, Republic of Korea; Department of Chemistry and Biochemistry, Faculty of Arts and Science, Concordia University, 7141, Sherbrooke St. W, Montreal, Quebec, Canada; Department of Biology, Faculty of Arts and Science, Concordia University, 7141, Sherbrooke St. W, Montreal, Quebec, Canada; Centre for Structural and Functional Genomic, Dept. of Biology, Faculty of Arts and Science, Concordia University, 7141, Sherbrooke St. W, Montreal, QC, Canada.
Publications dans "Proenzymes" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry and Molecular Biology, University of Calgary, T2N 1N4, Alberta, Canada.
Publications dans "Proenzymes" :
1 publication dans cette catégorie
Affiliations :
Department of Chemistry , Texas A&M University , College Station , Texas 77843 , United States.
Publications dans "Proenzymes" :
1 publication dans cette catégorie
Affiliations :
Department of Chemistry , Texas A&M University , College Station , Texas 77843 , United States.
Publications dans "Proenzymes" :
1 publication dans cette catégorie
Affiliations :
Department of Chemistry , Texas A&M University , College Station , Texas 77843 , United States.
Publications dans "Proenzymes" :
1 publication dans cette catégorie
Affiliations :
Department of Chemistry , Texas A&M University , College Station , Texas 77843 , United States.
Publications dans "Proenzymes" :
1 publication dans cette catégorie
Affiliations :
Department of Chemistry , Texas A&M University , College Station , Texas 77843 , United States.
Publications dans "Proenzymes" :
1 publication dans cette catégorie
Affiliations :
Center for Protein Assemblies, Technical University of Munich, Garching, Germany.
Publications dans "Proenzymes" :
1 publication dans cette catégorie
Affiliations :
Department of Bioorganic Chemistry, Max Planck Institute for Chemical Ecology, Jena, Germany.
Publications dans "Proenzymes" :
1 publication dans cette catégorie
Affiliations :
Department of Bioorganic Chemistry, Max Planck Institute for Chemical Ecology, Jena, Germany. boland@ice.mpg.de.
Publications dans "Proenzymes" :
1 publication dans cette catégorie
Affiliations :
Center for Protein Assemblies, Technical University of Munich, Garching, Germany. michael.groll@tum.de.
Publications dans "Proenzymes" :
1 publication dans cette catégorie
Affiliations :
Food Technology Department, Higher Technical School of Agrarian Engineering of Palencia, University of Valladolid, Av. Madrid 50, 34004 Palencia, Spain.
Publications dans "Proenzymes" :
1 publication dans cette catégorie
Affiliations :
Food Technology Department, Higher Technical School of Agrarian Engineering of Palencia, University of Valladolid, Av. Madrid 50, 34004 Palencia, Spain.
Publications dans "Proenzymes" :
Malignant nephrosclerosis is a thrombotic microangiopathy associated with abnormal local activation of the complement alternative pathway (AP). However, the mechanism underlying local AP activation is...
Complement factor D (FD) is a serine protease present predominantly in the active form in circulation. It is synthesized as a zymogen (pro-FD), but it is continuously converted to FD by circulating ac...
Kidney injury is one of the detrimental consequences of primary malignant hypertension (pMHTN). There is a paucity of non-invasive biomarkers to enhance diagnosis and elucidate the underlying mechanis...
Dense connective tissues (DCTs) such as tendon, ligament, and cartilage are important stabilizers and force transmitters in the musculoskeletal system. The healing processes after DCT injuries are hig...
Quantitative mass spectrometry (QMS) profiling of tissue biopsies from the inflammatory phase of healing (n = 40 patients) and microdialysates from the proliferative phase of healing (n = 28 patients)...
The QMS profiling of tissue biopsies from the inflammatory phase of healing identified 769 unique proteins, and microdialysates from the proliferative phase of healing identified 1423 unique proteins ...
The results of the current studies characterized underlying inflammatory- and proliferative healing mechanisms by which CFD potentially improved tendon repair. These findings may lead to improved indi...
http://clinicaltrials.gov, identifiers NCT02318472, NCT01317160....
The complement system, particularly the alternative complement pathway, may contribute to vascular damage and development of cardiovascular disease (CVD). We investigated the association of factor D, ...
In 2947 participants (50.6% men, 59.9 ± 8.2 years, 26.5% type 2 diabetes [T2D], oversampled) we measured markers of low-grade inflammation (LGI, composite score, in SD) and, endothelial dysfunction (E...
Factor D (per SD) significantly associated with LGI (0.171 SD [0.137; 0.205]), ED (0.158 SD [0.123; 0.194]) and CVD (OR 1.15 [1.04; 1.27]) but not significantly with cIMT (-6.62 μm [-13.51; 0.27]) or ...
Plasma factor D is independently associated with LGI, ED, and prevalent CVD but not with ABI or cIMT. Hence, greater plasma factor D concentration in CVD may potentially induce complement activation w...
Fibromyalgia (FM) is a syndrome characterized by chronic musculoskeletal pain. Its clinical symptoms include both somatic and psychiatric symptoms, making the treatment of FM extremely challenging. Th...
In this study, we screened genes and secreted factors that play key roles in FM through bioinformatics and big data analysis. Furthermore, we performed CCK-8, qRT-PCR, glucose, ATP and lactate content...
In bioinformatics and big data analysis, we identified CFD was negatively correlated with the pro-inflammatory factor IL-6 and positively correlated with the anti-inflammatory factor IL-4, which sugge...
In summary, based on bioinformatic methods and big data mining we obtained a new target CFD for FM, and further experiments verified that CFD has significant inhibition of ATP-induced neuropathic pain...
Paroxysmal nocturnal hemoglobinuria (PNH) is a rare hematological disorder characterized by episodic hemolysis, with additional clinical manifestations including thrombosis and bone marrow failure. Th...
We systematically searched for articles on PubMed, Web of Science, and three publishers Springer, Elsevier, Wiley up to May 6, 2024....
Danicopan acts on the alternative pathway of the complement cascade, preferentially controlling C3 fragment-mediated extravascular hemolysis. Recommended dosage is 150 mg orally three times a day, whi...
Acute myeloid leukemia (AML) is a hematologic malignancy characterized by aggressive proliferation and a poor prognosis. The objective of this study is to elucidate the specific role of complement fac...
We performed a systematic investigation on clinical significance and potential function of CFD in AML by using the R Programming Language with The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (...
The expression of CFD was the highest in AML cells than in other tumor cell lines. The expression of CFD was also higher in AML patients than in the matched normal group. Compared with the low express...
CFD could serve as a potential OS prognostic biomarker and guide clinical treatment for AML....
The tumor immune microenvironment is distinct between early-onset and late-onset colorectal cancer which facilitates tumor progression. We previously identified several genes, including complement fac...
This study aimed to assess and validate differential expression of immune genes in early and late-onset colorectal cancer. We also aimed to test known drugs targeting genes increased in early-onset co...
Retrospective cohort study with analysis performed using tumor RNA from formalin-fixed paraffin-embedded, cell culture and immunohistochemistry to validate gene expression and gene function. In vivo p...
Oregon Colorectal Cancer Registry was queried to find patients with colorectal cancer....
Study included 67 patients with early and 54 patients with late-onset colorectal cancer....
Preclinical animal models using the HCT-116 colon cancer cell line were treated with complement factor D inhibitor danicopan and BCL2 inhibitor venetoclax, or with vehicle controls....
Elevated RNA signatures using NanoString data was evaluated from the retrospective cohort. When inhibiting these markers in the mouse preclinical model, tumor volume and weight were the main outcome m...
After updating our sample size from our previously published data, we found that complement factor D and BCL2, genes with known function and small molecule inhibitors, are elevated in patients with ea...
This study is limited by small sample size and a subcutaneous tumor model....
Combinatorial inhibition of early-onset associated genes complement factor D and BCL2 slows growth of early-onset colorectal cancer in a mouse preclinical model. See Video Abstract....